tyrosine has been researched along with Cardiac Diseases in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (5.26) | 18.2507 |
2000's | 13 (68.42) | 29.6817 |
2010's | 5 (26.32) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, L; Cong, W; Jin, L; Li, X; Ma, W; Tan, Y; Wang, Y; Zhao, T; Zhu, Z | 1 |
Barnucz, E; Gwanmesia, PN; Hirschberg, K; Korkmaz, S; Li, S; Loganathan, S; Mátyás, C; Merkely, B; Németh, BT; Oláh, A; Páli, S; Radovits, T; Szabó, G; Zubarevich, A | 1 |
Baram, SM; Dehpour, AR; Rahimian, R; Rahmatollahi, M; Saeedi Saravi, SS | 1 |
Conte, D; Minas, JN; Nishiyama, A; Ortiz, RM; Thorwald, MA; Vázquez-Medina, JP | 1 |
Amirtharaj, GJ; Balasubramanian, KA; Natarajan, SK; Pulimood, A; Ramachandran, A; Venkatraman, A | 1 |
Bátkai, S; Haskó, G; Kashiwaya, Y; Liaudet, L; Mukhopadhyay, P; Pacher, P; Rajesh, M; Szabó, C | 1 |
Jia, D; Li, Y; Nie, X; Yan, Z; Zhao, Y; Zhou, Y; Zhou, Z | 1 |
Csont, T; Ferdinandy, P; Khadour, FH; Lalu, MM; Panas, D; Schulz, R; Schulze, C; Wildhirt, SM | 1 |
Cai, L; Kang, YJ; Li, Y; Sun, X; Wang, J; Wang, L; Zhou, Z | 1 |
Fang, CX; Ren, J; Wu, S | 1 |
Abrahani, A; Allard, MF; An, D; Ghosh, S; Innis, SM; Kewalramani, G; Pulinilkunnil, T; Qi, D; Rodrigues, B; Wambolt, RB; Yuen, G | 1 |
Beller, CJ; Berger, I; Chen, SH; Gero, D; Groves, JT; Lin, LN; Radovits, T; Seres, L; Szabó, C; Szabó, G; Zotkina, J | 1 |
Aligiannis, N; Andreadou, I; Gorgoulis, V; Iliodromitis, EK; Kremastinos, DT; Papaefthimiou, M; Papalabros, E; Savvari, P; Sigala, F; Sigalas, C | 1 |
Bencsik, P; Bereczki, E; Csonka, C; Csont, T; Ferdinandy, P; Fodor, G; Görbe, A; Puskás, LG; Sántha, M; Zvara, A | 1 |
Ba, ZF; Bland, KI; Chaudry, IH; Chen, J; Choudhry, MA; Hsu, JT; Kan, WH; Schwacha, MG | 1 |
Vinten-Johansen, J | 1 |
Willerson, JT; Wu, KK | 1 |
Berger, PB; Braden, GA; Casterella, PJ; Dangas, G; Gallo, R; Holmes, DR; Jia, G; Kereiakes, DJ; Lincoff, AM; Moliterno, DJ; Navetta, FI; Popma, JJ; Sane, DC; Saucedo, JF; Steinhubl, SR; Talley, JD; Tcheng, JE; Teirstein, PS; Theroux, P | 1 |
Arenas-Díaz, G; Marshall, SH; Muñoz, GE | 1 |
2 trial(s) available for tyrosine and Cardiac Diseases
Article | Year |
---|---|
Efficacy and safety of tirofiban in high-risk patients with non-ST-segment elevation acute coronary syndromes.
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Biomarkers; Creatine Kinase, MB Form; Double-Blind Method; Electrocardiography; Female; Heart Diseases; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Risk Assessment; Thrombocytopenia; Time Factors; Tirofiban; Treatment Outcome; Troponin I; Tyrosine | 2009 |
Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study.
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Blood Platelets; Cohort Studies; Eptifibatide; Female; Heart Diseases; Humans; Immunoglobulin Fab Fragments; Logistic Models; Male; Multivariate Analysis; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Risk Factors; Time Factors; Tirofiban; Tyrosine | 2001 |
17 other study(ies) available for tyrosine and Cardiac Diseases
Article | Year |
---|---|
Metallothionein prevents diabetes-induced cardiac pathological changes, likely via the inhibition of succinyl-CoA:3-ketoacid coenzyme A transferase-1 nitration at Trp(374).
Topics: Animals; Coenzyme A-Transferases; Diabetes Mellitus, Experimental; Disease Models, Animal; Energy Metabolism; Heart Diseases; Male; Metallothionein; Mice; Mice, Inbred Strains; Mice, Transgenic; Myocardium; Nitrogen; Protein Structure, Tertiary; Superoxides; Tryptophan; Tyrosine | 2013 |
An altered pattern of myocardial histopathological and molecular changes underlies the different characteristics of type-1 and type-2 diabetic cardiac dysfunction.
Topics: Animals; Apoptosis; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fibrosis; Gene Expression Regulation; Heart; Heart Diseases; Hemodynamics; Immunohistochemistry; In Situ Nick-End Labeling; Male; Myocardium; Oxidative Stress; Rats; Rats, Sprague-Dawley; Rats, Zucker; RNA, Messenger; Transforming Growth Factor beta1; Tyrosine; Ventricular Function, Left | 2015 |
Peroxisome Proliferator-Activated Receptor-α Inhibition Protects Against Doxorubicin-Induced Cardiotoxicity in Mice.
Topics: Animals; Atrial Function, Left; Benzoxazines; Cannabinoid Receptor Agonists; Cardiotonic Agents; Cardiotoxicity; Cytoprotection; Disease Models, Animal; Doxorubicin; Heart Diseases; Male; Malondialdehyde; Mice, Inbred BALB C; Morpholines; Myocardial Contraction; Myocytes, Cardiac; Naphthalenes; Oxazoles; PPAR alpha; Signal Transduction; Tumor Necrosis Factor-alpha; Tyrosine | 2016 |
Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats.
Topics: Adrenal Glands; Aldehydes; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biomarkers; Blood Pressure; Disease Models, Animal; Drug Therapy, Combination; Eplerenone; Heart Diseases; Hypertension; Lipid Peroxidation; Losartan; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Oxidative Stress; Rats, Sprague-Dawley; Renin-Angiotensin System; Signal Transduction; Spironolactone; Time Factors; Tyrosine | 2015 |
Role of Oxygen Free Radicals, Nitric Oxide and Mitochondria in Mediating Cardiac Alterations During Liver Cirrhosis Induced by Thioacetamide.
Topics: Animals; Chemical and Drug Induced Liver Injury; Female; Heart Diseases; Lipid Peroxidation; Liver; Liver Cirrhosis; Male; Mitochondria, Heart; Mitochondrial Swelling; Myocytes, Cardiac; Nitrates; Nitric Oxide; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Rats, Wistar; Reactive Oxygen Species; Signal Transduction; Thioacetamide; Time Factors; Tyrosine | 2017 |
Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Apoptosis; Cell Line; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Inhibitors; Free Radical Scavengers; Heart Diseases; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Heart; Myocardial Contraction; Myocytes, Cardiac; Necrosis; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Peroxynitrous Acid; Poly(ADP-ribose) Polymerases; Superoxides; Tyrosine; Ventricular Function, Left; Ventricular Pressure | 2009 |
Enhanced NO and superoxide generation in dysfunctional hearts from endotoxemic rats.
Topics: Animals; Endotoxemia; Heart Diseases; Hydrogen Peroxide; Lipopolysaccharides; Male; Myocardial Contraction; Myocardium; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Oxygen Consumption; Peroxynitrous Acid; Rats; Rats, Sprague-Dawley; Sepsis; Superoxides; Tyrosine; Xanthine Oxidase | 2002 |
Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy.
Topics: Animals; Cardiomyopathies; Diabetes Complications; Gene Expression; Heart Diseases; Male; Metallothionein; Mice; Mice, Transgenic; Nitrosation; Superoxides; Tyrosine | 2005 |
Intracerebral hemorrhage elicits aberration in cardiomyocyte contractile function and intracellular Ca2+ transients.
Topics: Animals; Calcium Signaling; Calcium-Binding Proteins; Calcium-Transporting ATPases; Cerebral Hemorrhage; Collagenases; Female; Gene Expression Regulation; Heart Diseases; Hypoxia-Inducible Factor 1, alpha Subunit; I-kappa B Proteins; Kv1.2 Potassium Channel; Myocardial Contraction; Myocytes, Cardiac; Nitric Oxide Synthase Type II; Phosphorylation; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sodium-Calcium Exchanger; Time Factors; Tyrosine | 2006 |
Induction of mitochondrial nitrative damage and cardiac dysfunction by chronic provision of dietary omega-6 polyunsaturated fatty acids.
Topics: Animals; Blotting, Western; Diet; DNA, Mitochondrial; Fatty Acids, Omega-6; Fluorescent Antibody Technique; Gene Expression; Heart Diseases; Lipid Peroxides; Male; Mitochondria, Heart; Nitric Oxide Synthase Type II; Oxidative Stress; Phospholipases A; Plant Oils; Rats; Rats, Wistar; Sunflower Oil; Superoxide Dismutase; Tyrosine | 2006 |
The peroxynitrite decomposition catalyst FP15 improves ageing-associated cardiac and vascular dysfunction.
Topics: Acetylcholine; Aging; Animals; Aorta; Diastole; Endothelium, Vascular; Heart Diseases; In Vitro Techniques; Male; Metalloporphyrins; Muscle, Smooth, Vascular; Nitric Oxide Synthase Type III; Oxidative Stress; Poly(ADP-ribose) Polymerases; Rats; Rats, Inbred Strains; Tyrosine; Vasodilation; Ventricular Function, Left | 2007 |
Acute doxorubicin cardiotoxicity is successfully treated with the phytochemical oleuropein through suppression of oxidative and nitrosative stress.
Topics: Acute Disease; Animals; Doxorubicin; Heart Diseases; Iridoid Glucosides; Iridoids; Male; Malondialdehyde; Nitrates; Nitric Oxide Synthase Type II; Nitrosation; Oleaceae; Oxidative Stress; Pyrans; Rats; Rats, Wistar; Tyrosine | 2007 |
Hypercholesterolemia increases myocardial oxidative and nitrosative stress thereby leading to cardiac dysfunction in apoB-100 transgenic mice.
Topics: Animals; Apolipoprotein B-100; Cholesterol; Cholesterol, Dietary; Female; Heart Diseases; Humans; Hypercholesterolemia; Immunohistochemistry; Metalloporphyrins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Animal; Myocardium; NADPH Oxidases; Nitric Oxide Synthase; Oxidation-Reduction; Oxidative Stress; Peroxynitrous Acid; Regional Blood Flow; Superoxides; Triglycerides; Tyrosine | 2007 |
p38 MAPK-dependent eNOS upregulation is critical for 17beta-estradiol-mediated cardioprotection following trauma-hemorrhage.
Topics: Abdomen; Animals; Calmodulin; Cardiotonic Agents; Caveolin 1; Chemokine CXCL1; Chemokine CXCL2; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Estradiol; Heart Diseases; Imidazoles; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Mitogen-Activated Protein Kinase 11; Myocardium; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Peroxidase; Phosphorylation; Pyridines; Rats; Rats, Sprague-Dawley; Shock, Hemorrhagic; Tumor Necrosis Factor-alpha; Tyrosine; Up-Regulation; Ventricular Function | 2008 |
Physiological effects of peroxynitrite: potential products of the environment.
Topics: Animals; Blood Physiological Phenomena; Cats; Crystalloid Solutions; Cytokines; Glutathione; Heart; Heart Diseases; Heart Ventricles; Humans; Isotonic Solutions; Myocardial Infarction; Nitrates; Nitric Oxide; Perfusion; Plasma Substitutes; Superoxides; Tyrosine | 2000 |
Monitoring platelet function in glycoprotein IIB/IIIA inhibitor therapy.
Topics: Abciximab; Antibodies, Monoclonal; Eptifibatide; Heart Diseases; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine | 2001 |
Exogenously added free phosphotyrosine induces aggregation of circulating platelets in rabbits.
Topics: Animals; Cells, Cultured; Electrocardiography; Heart Diseases; In Vitro Techniques; Phosphotyrosine; Platelet Activation; Platelet Aggregation; Rabbits; Tyrosine | 1992 |